LATE STAGE ONCOLOGY MCDA CRITERIA IMPLEMENTATION RESULTS IN EUROPEAN COUNTRIES

Author(s)

Bertalan Nemeth, MSc, Syreon Research Institute, Budapest, Hungary; Oresta Piniazhko, PhD, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine; Aleksandra Zawodnik, MSc Pharm, Medical University of Warsaw, Warsaw, Poland

Late stage oncology Multi-Criteria Decision Analysis (MCDA) inter- dependence of the following criteria will be explored: efficacy, budget impact, safety, unmet needs, strategic & patient preference. Introduction to each criteria will be provided to the audience. Scoring comparison between different countries will be performed. Presenters will demonstrate late stage oncology MCDA criteria transferability and application across European countries. Audience engagement is anticipated during the meeting.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Code

F9

Topic

Health Technology Assessment, Organizational Practices

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×